Moderna, Inc.
Long

$MRNA road to lazy 5?

485
New positive updates came out regarding their phase one vaccine trial
Projected 4 broke down but managed to bounce back

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.